Crossmark

RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies

Crossref DOI link: https://doi.org/10.15252/emmm.202215811

Published Online: 2022-03-14

Published Print: 2022-04-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

McMillan, Nigel A J https://orcid.org/0000-0002-9471-1406
Morris, Kevin V https://orcid.org/0000-0002-0157-0553
Idris, Adi https://orcid.org/0000-0002-0562-1549
License Information

Version of Record valid from 2022-03-14
More Information

Publication History

Received: 2022-02-16

Accepted: 2022-02-17

Published: 2022-03-14